Ph.D. Raymond C. Stevens - 03 Mar 2026 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: GPCR
Reported as of: 03 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Mar 2026, 18:20:05 UTC
Prior SEC filing: 03 Feb 2026
Next SEC filing: 23 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jun Yoon, Attorney-in-Fact

Key filing fact

Ph.D. Raymond C. Stevens filed Form 4 for Structure Therapeutics Inc. (GPCR) on 05 Mar 2026.

Key facts

This page summarizes Ph.D. Raymond C. Stevens's Form 4 filing for Structure Therapeutics Inc. (GPCR).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 05 Mar 2026, 18:20.

Change

Previous filing in this sequence was filed on 03 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001698149 Primary reporting owner

Stevens Raymond C

Relationship: CHIEF EXECUTIVE OFFICER, Director
Address: C/O STRUCTURE THERAPEUTICS INC., 601 GATEWAY BLVD., SUITE 900, SOUTH SAN FRANCISCO
Signature: /s/ Jun Yoon, Attorney-in-Fact
Signature date: 05 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GPCR transaction

Ordinary Shares

Tax liability

Transaction value
Shares: -53,454
Change %: -4.5%
Price: $20.99^*
Shares after: 1,141,376
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F1, F2

GPCR holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,554,586
Date: 03 Mar 2026
Ownership: See footnote
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GPCR transaction Derivative

American Depositary Shares

Award

Transaction value
Shares: +824
Change %: +82%
Price: $0.000000^*
Shares after: 1,824
Date: 20 Nov 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,472
Exercise price
Footnotes: F1, F4, F5

GPCR holding Derivative

American Depositary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,000
Date: 03 Mar 2026
Ownership: See footnote
Underlying class: Ordinary Shares
Underlying amount: 12,000
Exercise price
Footnotes: F1, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Footnote F2

Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.

Footnote F3

By Raymond Stevens and Vivian Urena-Stevens, as Co-Trustees of the Stevens 2001 Revocable Trust, dated March 28, 2001.

Footnote F4

Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

Footnote F5

Voluntary reporting of the acquisition of 824 ADSs by the Reporting Person on November 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan.